Product Manager, Beacon Biosignals
$135-170k
Plus equity
AI brain monitoring
Job no longer available
AI brain monitoring
21-100 employees
Job no longer available
$135-170k
Plus equity
21-100 employees
Company mission
To improve human health by enabling rapid, targeted interventions through advanced brain analytics.
Role
Who you are
- You've worked as a product manager for data-driven B2B products. You can clearly explain the impact of your efforts on those products, and the impact of those products on business outcomes
- You've demonstrated success collaborating with cross-functional teams of engineers and designers throughout the product life cycle
- You understand that product development is a strategic endeavor. You've crafted and driven effective product strategies in your past roles, and know when to adapt methodologies to fit the immediate needs of the team
- You're comfortable working in an asynchronous environment, and have demonstrated success working remotely in the past
- You have experience working in the realm of data and analytics and have experience explaining the complexity of decisions to stakeholders and customers
Desirable
- You have experience in ML or AI products
- You have experience working in health or biotech and you're motivated to have a huge impact on the industry and on real patients' lives
- You’ve worked in a heavily regulated product market space
What the job involves
- Beacon Biosignals is seeking a Product Manager II to join the Product Department in helping us build our machine-learning-enabled brain health platform to accelerate precision treatment for millions of patients with severe neurological and psychiatric disease
- This role will report to the Director of Product
- Work cross-functionally across several teams and projects
- Build a deep knowledge of our internal and external users, customers, partners, and the biopharma ecosystem in which Beacon operates
- Map the opportunity space for the Beacon Platform, and drive product vision, strategy, and roadmaps in the context of the company's broader strategy and goals
- Practice continuous discovery by ensuring that you and your team are consistently speaking with users, challenging your assumptions, and testing your solutions
- Leverage Beacon's unique next-generation scientific computing capabilities to ship valuable, high quality products and features that delight users and maximize Beacon's impact
- Value outcomes over output and define success in terms of the value created for customers
- Take a scientific approach to product development by continuously challenging assumptions, gathering evidence, testing hypotheses, and validating outcomes
Our take
The brain has long been considered one of the most mysterious fields of medicine - and psychiatric and neurological diseases therefore one of the least understood. Better access to real-time brain data, however, could change this. That’s exactly what Beacon Biosignals is hoping to deliver.
Beacon Biosignals has developed a scalable electroencephalogram (EEG) analytics platform that leverages AI to more accurately and insightfully manage brain data. Its capabilities run from analysing existing data, to identifying and standardising neorobiomarkers, to continuously aggregating and analysing trial data.
The hope is that this will help clinical brain researchers carry out faster and more accurate work, ultimately accelerating the pace of treatment development in neurology. It’s a smart new AI application, and Beacon Biosignals is acquiring new companies to scale and receiving handsome funding - but for that reason the company isn’t alone in pursuing it. Bitbrain is also developing neurology AI, although with a tighter focus on product development. This may help differentiate Beacon Biosignals in what is still a relatively new market area.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
40% employee growth in 12 months
Company
Funding (last 2 of 4 rounds)
Nov 2025
$86m
SERIES B
Nov 2021
$27m
SERIES A
Total funding: $116.5m
Company HQ
Beacon Hill, Boston, MA
Leadership
Jarrett Revels
(Co-Founder & CTO)Previously a Software Engineer at MissionFocus, who then moved into various engineering and research roles at MIT.
Jacob Donoghue
(Co-Founder & CEO)Completed a Neuroscience PhD at MIT, and received his MD from Harvard Medical School. Subsequently carried out research for Cyberkinetics Neurotechnology Systems and Massachusetts General Hospital.
Brandon Westover
(Co-Founder)Received his MD from Washington University School of Medicine, then took up a Neurology residency at Harvard Medical School. Alongside his work at Beacon Biosignals, is also an HST Faculty member at MIT and a Neurologist/Medical AI Researcher at Massachusetts General Hospital.
Syd Cash
(Co-Founder)An Associate Professor at Harvard Medical School, who also leads the Center for Neurotechnology and Neurorecovery at MGH.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 3 more jobs at Beacon Biosignals